# OLANZAPINE

NDC: 83854-003
Generic name: OLANZAPINE
Labeler / Manufacturer: Anthea Pharma Private Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAMUSCULAR
Marketing started: 20260305

FDA application: ANDA220323

## Active ingredients

- OLANZAPINE: 10 mg/2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83854-003"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83854-003
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e6ffcc56-63f9-4b12-a07a-c6177ffef5e8